Updated
- Log In
- Newsletters
-
Subscribe
Access insights and guidance from our Wall Street pros. Find the product that's right for you.
Fundamental Analysis
Economist Perspective: Why 2019 Will Be Different?
Will lag effects of interest rate hikes and the trade war with China show up in 2019?
How This Former VC Player Became CEO of $2 Billion Cannabis Company Tilray
With Tilray set to report earnings after today's closing bell, we're rewinding to our sit-down with CEO Brendan Kennedy.
Trader's Edge: WTI/Brent Spread
Key advantages of using options when trading a WTI/Brent spread
Economist Perspective: Trade War
Will the unintended effects of the trade war show up in 2019?
Striking Options: Elections, Equities, & Nasdaq
U.S. stocks rise as investors eagerly await U.S. midterm results
Market Movers: Trading Around Midterm Elections
Power Balance: Will a shift in politics change investors risk appetite in the U.S. dollar and gold?
Jim Cramer: No One Took Price This Quarter Better Than Apple
They are coining money selling phones and making even more - in terms of gross profit on the services stream.
Get Bearish on Shake Shack With This Options Play
SHAK beat expectations for both EPS and revenue, but same-store sales decreased. Here is how to play it.
These Are the U.S. Regions Most Affected by Retaliatory Tariffs
Many local economies in the U.S. — cities, towns, and rural areas — depend on exports for economic growth and jobs.
Jim Cramer: Even Safe-Haven Big-Cap Drug Stocks Are Now Broken
Once the safest stocks in the book, the big-cap drug companies are now toxic.